Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma - Top-Institutions - MDSpire

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma

  • By

  • Dan Xu

  • Daqing Huang

  • Zhijie Li

  • Yan Yan

  • Zhencun Cui

  • Zhongfang Zhao

  • Xiaoju Chen

  • Maolong Chen

  • Xiongxiong Liu

  • Zhaobo Zhou

  • Qianxi Ni

  • Taofeng Zhang

  • Hui Wang

  • Qi Zeng

  • Xi’an Xiong

  • Bin Liu

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #3

    UCI Health
    UCI Health

    Irvine, California

    Key Differentiators

    • Oncology

  • #4

    Mass General Brigham Cancer Institute
    Mass General Brigham Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #5

    Erasmus University Medical Center
    Erasmus University Medical Center

    Rotterdam, Netherlands

    Key Differentiators

    • Oncology

Original Source(s)

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma

  • by Dan Xu, Daqing Huang, Zhijie Li, Yan Yan, Zhencun Cui, Zhongfang Zhao, Xiaoju Chen, Maolong Chen, Xiongxiong Liu, Zhaobo Zhou, Qianxi Ni, Taofeng Zhang, Hui Wang, Qi Zeng, Xi’an Xiong, Bin Liu

  • July 14, 2026

Related Content

Case Report: Preoperative embolization for a large intracranial pheochromocytoma metastasis: a novel approach to minimize intraoperative risk

Tumor-associated macrophages and lineage plasticity in prostate cancer: from established myeloid programs to emerging spatial hypotheses

Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation